Enabling Unprecedented Advances
The COLS Team
Larry Gold, Ph.D.Chairman of the Board
Larry Gold is the founder and chairman of the board, and past CEO of SomaLogic. Prior to SomaLogic, he founded NeXagen, Inc., which later became NeXstar Pharmaceuticals, Inc. In 1999, NeXstar merged with Gilead Sciences, Inc. to form a global organization committed to the discovery, development, and commercialization of novel products that treat infectious diseases.
During nearly 10 years at NeXstar, Gold held numerous executive positions including chairman of the board, executive vice president of R&D, and chief science of icer. Before forming NeXagen, he also co-founded and served as co-director of research at Synergen, Inc., a pioneering biotechnology company later acquired by Amgen, Inc. Since 1970, Gold has been a professor at the University of Colorado Boulder. He served as the chairman of the molecular, cellular, and developmental biology department from 1988 to 1992.
Gold received the CU Distinguished Lectureship Award, the NIH Merit Award, the Career Development Award, and the Chiron Prize for Biotechnology. In addition, Gold has been a member of the American Academy of Arts and Sciences since 1993 and the National Academy of Sciences since 1995.
Gold also serves on the board of directors of CompleGen and Plato BioPharma, and is a member of the Institute for Genome Biology External Advisory Board at the University of Illinois at Urbana-Champaign.
Phyllis M. Wise, Ph.D.CEO, President, Board Member
Phyllis Wise is a leader in higher education and biomedical researcher. She has served as chief executive officer and chief academic and budgetary officer at pre-eminent research universities. She has been a passionate advocate for public research universities and the role they must play in meeting society’s greatest global challenges. With over thirty years of research funding from the National Institutes of Health, among other funding agencies, Dr. Wise’s research focuses on issues women’s health and how hormones influence learning and memory and protect the brain against neurodegeneration. She is a member of the National Academy of Medicine and the American Academy of Arts and Sciences.
As the Chancellor at the University of Illinois at Urbana-Champaign and Interim President and Provost at the University of Washington and, she led the development of shared visions and strategic plans that positioned these institutions for future decades. With over 40,000 students and 3,000 faculty, and multi-billion dollar budgets, including research portfolios of over a billion dollars at each of these institutions, Dr. Wise promoted an environment that enabled cutting edge discoveries, collaborative and interdisciplinary scholarship, innovative learning opportunities, and deep engagement with partners around the world.
Dr. Wise has significant corporate and foundation board experience and currently serves on the NIKE and the First Busey Corporation Boards of Directors. In the non-profit sector, she serves on the Robert Wood Johnson Foundation Board of Directors and the RAND Health Boards of Advisors. She was recognized as a “Woman of Influence” by the Puget Sound Business Journal and has received several awards that recognize her leadership in education including the Asian Pacific Americans in Higher Education Leadership Award and the Chang-Lin Tien Educational Leadership Award.
Dr. Wise received her bachelor’s degree from Swarthmore College and her Ph.D. from the University of Michigan. She holds honorary degrees from Swarthmore College and the University of Birmingham (England).
Meredith E. GrahamChief of Staff, Secretary
Meredith Graham is the executive director of the GoldLab Foundation. After receiving her bachelor’s degree in Psychology and English from the University of Massachusetts, Amherst, Meredith took a job with Bain & Company’s global headquarters in Boston. She spent four years at Bain, where she was part of a core team that created an investment fund subsidiary. She left Bain for graduate school. At New York University, she received a master’s degree in Integrated Marketing, a program that focused on quantitative metrics, direct marketing fundamentals, social media, and ROI analysis by channel.
Meredith originally intended to work in the fashion industry and held internships at Prada and Ann Taylor. However, while in graduate school, Meredith lost both of her parents to preventable diseases. That life-changing experience convinced her to pursue a more meaningful, fulfilling path in work and life.
Consequently, after she received her master’s degree she moved to Boulder, Colorado. In Boulder, she worked as a Marketing Strategy Consultant until she teamed up with Larry Gold to form The GoldLab Foundation. In her capacity as Executive Director, she worked closely with Dr. Gold to create the initial plan for the Colorado Longitudinal Study. Now, with many more fantastic advisors, Meredith combines her marketing and leadership skills with collaborative spirit and passion for doing meaningful work to create the partnerships that will support COLS.
Marilyn E. Coors, Ph.D.Board Member
Marilyn E. Coors is Associate Professor of Bioethics at the Center for Bioethics and Humanities and the Department of Psychiatry at the University of Colorado Anschutz Medical Campus. The ethical issues in clinical and behavioral genomic research are the foci of her research, teaching and professional service.
Research interests pursued by Dr. Coors include the ethics of human genetic modification, ethical issues in genomic research in adolescents with substance use disorder and their parents, and community based participatory research on informed consent for biobanking. As the Director of Research Ethics for the Colorado Clinical and Translational Science Institute, she is directly involved in research ethics consultation and cross disciplinary ethics education. Coors is an Affiliate member of Colorado University Division of Substance Dependence and a Faculty Fellow at the Colorado University Institute of Behavioral Genetics.
Dr. Coors received her undergraduate education from Cornell University where she majored in biological sciences. She then attended the University of Denver, earning a M.S. in cytogenetics, a M.A. in ethics and religion, and a Ph.D. in bioethics. Coors serves on the Ethical, Legal & Social Issues (ELSI) Working Group of the Alpha-1 Foundation, the Advisory Board of the Alpha-1 Medical and Scientific Advisory Committee and the Board of Directors of the COPD Foundation Patient-Powered Research Network.
Donald M. Elliman Jr.Board Member
Elliman is currently Chancellor, University of Colorado Anschutz Medical Campus.
A long-time executive in publishing, Don Elliman boasts a successful track record in business and a high-quality reputation in higher education.
Elliman worked at Time Warner for 32 years, retiring as an executive vice president of Time Inc. Other positions he has held include publisher of People Magazine and President of Sports Illustrated.
He moved to Colorado and was hired as president of Ascent Sports then Kroenke Sports Enterprises, with oversight of business activities, including The Pepsi Center, The Denver Nuggets and The Colorado Avalanche.
Elliman next became the director of the Colorado Office of Economic Development and International Trade, overseeing a wide range of economic development activities, including domestic and international business development, small business programs, the Colorado Tourism Office and the Colorado Economic Development Commission.
He then served two years as chief operating officer for Colorado, assisting the governor in the management of all state agencies, and as chair of the Colorado Recovery Accountability Board, with responsibilities for oversight of spending in Colorado.
In 2011, Elliman was named executive director of the University of Colorado School of Medicine’s Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology on the Anschutz Medical Campus. He became interim chancellor for both the Denver and Anschutz campuses on April 2, 2012. He was named chancellor by University of Colorado President Bruce Benson on Feb. 20, 2013. He assumed sole responsibility for CU Anschutz on Sept. 23, 2014.
Elliman has served as chair of the Children’s Hospital Colorado Board of Directors and co-chair of the campaign to raise funds for the new hospital. He continues to serve on the board of Children’s Hospital Colorado as well as on the boards of UCHealth, University of Colorado Hospital, The Higher Learning Commission, The Denver Metro Chamber of Commerce, Fitzsimons Redevelopment Authority, The Gates Family Foundation, Linda Crnic Institute for Down Syndrome, National Behavioral Health Innovation Center, and the National Western Stock Show.